Risk calculators for the detection of prostate cancer: a systematic review.
Frederique B DenijsMeike J van HartenJonas J L MeenderinkRenée C A LeenenSebastiaan RemmersLionne D F VenderbosRoderick C N van den BerghKatharina BeyerMonique J RoobolPublished in: Prostate cancer and prostatic diseases (2024)
This systematic review offers an extensive analysis of currently available RCs, their variable utilization, and performance within validation cohorts. RCs have consistently demonstrated their capacity to mitigate the limitations associated with early detection and have been integrated into modern practice and screening trials. Nevertheless, the lack of external validation data raises concerns about numerous RCs, and it is crucial to factor in this omission when evaluating whether a specific RC is applicable to one's target population.